乳腺癌荷塞停治疗效果的预测
Prediction of therapeutic efficacy of Herception in breast cancer
摘要
乳腺癌中HER2 /neu基因扩增与预后不良密切相关。抗HER2 /neu癌蛋白的单抗荷塞停治疗乳腺癌已取得显著效果 ,但仅HER2 /neu过度表达的患者能受益于荷塞停治疗 ,因此治疗开始前确定患者癌组织HER2 /neu表达水平对治疗成功至关重要。
出处
《国外医学（临床生物化学与检验学分册）》
2004年第2期114-115,118,共3页
Foreign Medical Sciences(section of Clinical Biochemistry and Laboratory Medicine
参考文献11
-
1Seidman AD, Fornier MN, Esteva FJ, et al. Weekly trastuzumab and paclitaxel therapy for metastatic breast cance- with analysis of efficacy by HER2 immunophenotype and gene amplification. J Clin Oncol, 2001,19(10): 2587-2595.
-
2Ewer MS,Gibbs HR,Swafford J,et al. Cardiotoxicity in patients receiving transtuzumab (Hereeptin): primary toxicity, synergistic or sequential stress, or surveillance artifact ? Semin Oncol, 1999,26 ( 4Suppl 12) :96-101.
-
3Rhodes A,Jasani B, Anderson E, et al. Evaluation of HER-2/neu immunohistochemical assay sensitivity and scoring on formalin-fixed and paraffin-processed cell lines and breast tumors: a comparative study involving results from laboratories in 21 countries.
-
4Jacobs TW,Gown AM,Yaziji H,et al. Specificity of HercepTest in determining HER-2/neu status of breast cancers using the United States Food and Drug Administration-approved scoring system. J Clin Oncol, 1999,17(7): 1983-1987.
-
5Pauletti G,Dandekar S,Rong H,et al. Assessment of methods for tissue-based detection of the HER-2/hen alteration in human breast cancer:a direct comparison of fluorescence in situ hybridization and immunohistochemistry. J Clin Oncol,2000,18(21) :3651-3664
-
6Slamon DJ,Clark GM,Wong SG,et al. Human breast cancer:correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science, 1987,235 (4785): 177-182.
-
7Press MF,Bernstein L,Thomas PA,et al. HER-2/neu gene amplification characterized by fluorescence in situ hybridization:poor prognosis in node-negative breast carcinomas. J Clin Oncol, 1997,15(8):2894-2904.
-
8Lemoine NR, Staddon S, Dickson C, et al. Absence of activating transmembrane mutations in the c-erbB-2 proto-oncogene in human breast cancer. Oncogene, 1990,5(2) :237-239.
-
9Ridolfi RL,Jamehdor MR,Arber JM. HER-2/neu testing in breast carcinoma:a combined immunohistochemical and fluorescence in situ hybridization approach. Mod Pathol, 2000,13 (8) : 866-873.
-
10Pauletti G,Godolphin W,Press MF,et al. Detection and quantitation of HER-2/neu gene amplification in human breast cancer archival material using fluorescence in situ hybridization. Oncogene.1996,13(1) :63-72.
-
1方立俭,程艳莉,孙咏梅,张岩.PCNA和C-erbB-2在胃癌组织中的表达及临床意义[J].肿瘤防治杂志,2003,10(8):814-815. 被引量：2
-
2高斌斌,徐忠法.胃肠道间质瘤c-kit基因突变及其临床意义[J].国际肿瘤学杂志,2006,33(3):217-219.
-
3晋雯,林志武,高美钦,杨代兴.原癌基因蛋白质C-erb B-2及增殖细胞核抗原在结肠癌中的定量检测及临床意义[J].福建医科大学学报,2000,34(4):341-343.
-
4张继美,曹国樑,李祎.胃癌及癌前病变组织中C-erb-B_2蛋白检测的临床意义[J].中国误诊学杂志,2001,1(1):37-38.
-
5赵志华,陈可欣.Vav1在胃癌中的表达及其与预后的相关性[J].天津医药,2016,44(9):1120-1123. 被引量：1
-
6高冬霞,孟凡农,田旭阳,扬京萍,凌云,廖松林.胃肠道间质瘤的临床病理研究[J].中华普通外科杂志,2003,18(6):345-347. 被引量：6
-
7单礼成,范西红,贺青卿,范子义,尹格平.Fas/FasL在乳头状甲状腺癌组织中的表达[J].中国现代普通外科进展,2001,4(2):97-98. 被引量：3
-
8乔玉环,黄珊珊,郭瑞霞.17β-E_2对子宫内膜癌细胞增殖及其p-Erk表达的影响[J].山东医药,2008,48(33):1-3.
-
9秦荣,何振平.原癌基因蛋白质c-met核酶基因对胃癌细胞生物学行为的影响[J].中华胃肠外科杂志,2005,8(6):528-530. 被引量：3
-
10杨道华,易建华,朱礼国.乳腺癌C-erbB-2癌基因产物与雌激素受体和孕激素受体的相关性研究[J].郧阳医学院学报,2000,19(1):21-22.
